Figure 6H presents the proposed regulatory model of IGF2BP2 in CRC, in which IGF2BP2 promotes iron metabolism and tumor progression in CRC by regulating METTL4, thereby regulating the methylation of TFRC mRNA. The gene discussed is METTL4; the disease is neoplasm.